International Conference on AI and Bioinformatics in Drug Discovery (ICAIBDD - 26)

This track focuses on the latest developments in artificial intelligence applications for drug discovery. Participants will explore innovative AI methodologies that enhance the efficiency and accuracy of drug development processes.

This session will delve into the application of data science techniques in the analysis of biomedical data. Emphasis will be placed on methodologies that facilitate the extraction of meaningful insights from complex biological datasets.

This track will examine the role of machine learning in genomics, particularly in the context of genomic data analysis and interpretation. Researchers will present case studies demonstrating how machine learning algorithms can uncover genetic variations linked to diseases.

This session will highlight computational biology approaches that integrate biological data with computational models. Discussions will include the development of algorithms for simulating biological processes and predicting outcomes.

This track will explore the integration of artificial intelligence in proteomics research. Participants will discuss how AI can enhance protein analysis and facilitate biomarker discovery.

This session will focus on the intersection of systems biology and predictive analytics in drug discovery. Researchers will present methodologies that leverage systems biology frameworks to predict drug interactions and therapeutic outcomes.

This track will address the importance of workflow automation in bioinformatics research. Participants will explore tools and techniques that streamline data processing and analysis in drug discovery.

This session will examine the role of biomedical informatics in facilitating drug development processes. Discussions will include the use of informatics tools to manage and analyze clinical data effectively.

This track will focus on functional genomics approaches for identifying novel drug targets. Researchers will present findings on how functional genomics can inform therapeutic strategies.

This session will explore the advancements in protein structure prediction techniques and their implications for drug design. Participants will discuss computational methods that aid in understanding protein-ligand interactions.

This track will highlight the role of AI and data science in biomarker discovery for personalized medicine. Researchers will share insights on how advanced analytics can identify potential biomarkers for various diseases.